(Q41496925)

1 October 2017

1 reference

title

Changing paradigms in thrombolysis in acute myocardial infarction (English)

1 reference

1 October 2017

1 reference

Gotsman MS

1

1 reference

1 October 2017

Rozenman Y

2

1 reference

1 October 2017

Admon D

3

1 reference

1 October 2017

Mosseri M

4

1 reference

1 October 2017

Lotan C

5

1 reference

1 October 2017

Zahger D

6

1 reference

1 October 2017

Weiss AT

7

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

International Journal of Cardiology

1 October 2017

published in

1 reference

1 October 2017

volume

59

1 reference

1 October 2017

issue

3

1 reference

1 October 2017

page(s)

227-242

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Myocardial infarction patients in the 1990s--their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Antioxidants and atherosclerosis. A current assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Coronary thrombosis: pathogenesis and clinical manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Angiographic findings in the coronary arteries after thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Acute myocardial infarction - the angiographic picture: new insights into the pathogenesis of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

A perspective of coronary disease seen through the arteries of living man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

The earliest diagnosis of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Early intravenous thrombolysis in acute myocardial infarction: the Jerusalem experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Determinants of delay between symptoms and hospital admission in 5978 patients with acute myocardial infarction. The TRACE Study Group. Trandolapril Cardiac Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Tailored thrombolytic therapy. A perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Delay times in the administration of thrombolytic therapy: the Brighton experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Prehospital thrombolysis in rural emergency room and subsequent transport to a coronary care unit: Ravenna myocardial infarction (RaMI) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Time as a factor in thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Delay between onset of chest pain and seeking medical care: the effect of public education

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

The European Myocardial Infarction Project: an assessment of pre-hospital thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Prehospital coronary thrombolysis. A new strategy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Pre-hospital triage of patients with suspected myocardial infarction. Evaluation of previously developed algorithms and new proposals.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Direct thrombin inhibitors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Absence of lethal reperfusion injury after 3 hours of reperfusion. A study in a single-canine-heart model of ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocard

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

The open artery hypothesis: to open, or not to open, that is the question

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Early treatment of acute myocardial infarction with intravenous streptokinase. A high-risk syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Myocardial infarction and thrombolysis. Electrocardiographic short term and long term results using precordial mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Importance of two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Frequency of use of thrombolytic therapy in acute myocardial infarction in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2902957-4

7 January 2021

10.1016/S0167-5273(97)02957-4

Identifiers

DOI

1 reference

1 October 2017

1 reference